TRCT
BFT.U

Tower Research Capital (TRC)’s Foley Trasimene Acquisition Corp. II Units, each consisting of one share of Class A common stock, an BFT.U Stock Holding History

Tower Research Capital (TRC)’s Portfolio BFT.U Stock Details BFT.U Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-378
Closed -$6K – 6005
2020
Q4 		$6K Buy
+378
New +$4.5K ﹤0.01% 4592

Tower Research Capital (TRC)'s BFT.U Position: Q1 2021 in Review

Tower Research Capital (TRC) sold out of Foley Trasimene Acquisition Corp. II Units, each consisting of one share of Class A common stock, an (BFT.U) in Q1 2021, closing a stake of 378 shares — an estimated $6K sold.

Tower Research Capital (TRC) first reported a position in BFT.U in Q4 2020 and held it in 1 quarter. The position peaked at $6K in Q4 2020. 0 funds tracked by Wall St. Rank hold BFT.U as of Q1 2021.

  • Tower Research Capital (TRC) reported no remaining Foley Trasimene Acquisition Corp. II Units, each consisting of one share of Class A common stock, an position as of Q1 2021 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 378 Foley Trasimene Acquisition Corp. II Units, each consisting of one share of Class A common stock, an shares in Q1 2021, an estimated $6K.
  • Tower Research Capital (TRC) first reported a position in Foley Trasimene Acquisition Corp. II Units, each consisting of one share of Class A common stock, an in Q4 2020 and held it in 1 quarter.
  • Tower Research Capital (TRC)'s Foley Trasimene Acquisition Corp. II Units, each consisting of one share of Class A common stock, an position peaked at $6K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Foley Trasimene Acquisition Corp. II Units, each consisting of one share of Class A common stock, an as of Q1 2021.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.